September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Ahmed Alanazi: T-DXd Achieves Primary Endpoint in Early Breast Cancer Neoadjuvant Trial (DB-11)
May 9, 2025, 13:01

Ahmed Alanazi: T-DXd Achieves Primary Endpoint in Early Breast Cancer Neoadjuvant Trial (DB-11)

Ahmed Alanazi, Department Program Director at King Fahad Medical City, shared a post on X:

“BREAKING NEWS| PRESS RELASE
T-DXD at early setting breast cancer as NACT DB-11 TDXD followed by THP VS standard of care ddAC-THP achieved its primary endpoint pCR statistically and clinically meaningful
Rates of interstitial lung disease (ILD) were similar across the T-DXD followed by THP and the ddAC-THP arms
TDXD WINS AGAIN and now in eBC
waiting for 2ndry endpoints EFS in the future to be matured.”
Ahmed Alanazi

More posts featuring Breast Cancer on OncoDaily.